Clomiphene Citrate

Clomiphene Citrate competitively binds to estrogen receptors in the hypothalamus, preventing endogenous estrogen from exerting its effects. This disruption signals the pituitary gland to increase the production of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). Elevated LH levels stimulate the testes to produce more testosterone. It does not directly affect aromatase activity; it merely blocks estrogen's action at the receptor level. Users report varying degrees of effectiveness depending on individual hormonal profiles and cycle length.

Clomiphene Citrate is predominantly employed in post-cycle therapy (PCT) following the cessation of anabolic steroid use. Athletes typically run Clomiphene to counteract estrogenic rebound, which can manifest as gynecomastia, water retention, and suppressed natural testosterone levels. It may also be used in research contexts to investigate hypothalamic-pituitary-gonadal axis regulation. While less common, some users explore its potential for selective androgen receptor modulation (SARM) cycle support. It is not typically employed during active anabolic cycles.

For PCT research, a typical protocol involves initiating Clomiphene Citrate at 50 mg per day for the first two weeks, followed by a dose reduction to 25 mg per day for the subsequent two weeks. Some users opt for a tapering schedule of 25mg/day for an additional week. Total cycle duration rarely exceeds four weeks. Advanced researchers may utilize protocols up to 150mg/week, but this is not generally recommended. Bloodwork should be performed pre-cycle, mid-cycle and post-cycle to monitor hormone levels.

Commonly reported side effects include mood swings, visual disturbances (blurred vision, halos), headaches, and increased libido. Users report these are typically dose-dependent and subside after cycle completion. Clomiphene Citrate can potentially suppress LH production with prolonged use. A post-cycle therapy (PCT) protocol is crucial for restoring natural testosterone levels. Liver toxicity is not a significant concern; however, monitoring liver enzymes via bloodwork is advisable. Age 21+ only.

Mechanism of action

Clomiphene Citrate acts as a selective estrogen receptor modulator (SERM), competitively binding to estrogen receptors in the hypothalamus, resulting in increased gonadotropin-releasing hormone (GnRH) release and subsequent luteinizing hormone (LH) production.